课题基金 / 基金详情

Clinicopathological study of dementia : the Hisayama study

Clinicopathological study of dementia : the Hisayama study
痴呆症的临床病理学研究:久山研究
批准号:
16300112
负责人:
IWAKI Toru
金额:
$8.06万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

IWAKI Toru的其他基金

相似基金

相关文献

中文摘要
翻译
Hisayama研究是在日本郊区社区Hisayama Town进行的一项前瞻性基于人群的临床病理队列研究。大多数死者都经过尸检,以确认死因并检查脑部病理学。这些功能允许一个可靠的估计频率的神经退行性疾病相关的痴呆症在一般人群中,并详细分析痴呆症和非痴呆症之间的差异。在这项研究中,我们获得了以下发现。(1)We神经元缠结型老年痴呆(SD-NFT)占第四位(3.9%)。我们发现,SD-NFT患者海马NFT的数量并不一定超过阿尔茨海默病的程度,并且脑重量明显降低,其程度与阿尔茨海默病(AD)相同,这表明不仅边缘系统NFT病理,而且一些全脑功能障碍也可能导致SD-NFT患者的海马NFT数量减少。 ...更多信息 精神退化。(2)To为探讨环氧化酶(考克斯)-2在海马的表达,我们分析了45例连续尸检的非痴呆患者和25例AD患者。考克斯-2在海马CA 3区、下托、内嗅皮质和经内嗅皮质的神经元表达在非痴呆和AD脑中均一致地观察到,并且考克斯-2免疫反应性在非痴呆脑中与年龄相关。AD患者海马CA 1区考克斯-2阳性神经元的表达与AD的严重程度相关,而非痴呆组则无明显相关性。结果表明,考克斯-2的表达可能是不同的调节之间的细分的海马和升高的考克斯-2的表达在CA 1的AD大脑可能与AD的病理,从而认知功能障碍。(3)路易体痴呆(DLB)是第三大痴呆。为了验证2005年修订的标准的有效性,我们分析了205例连续的痴呆尸检病例。59例(28.8%)存在LB病理。女性DLB病例有更严重的LB病理和阿尔茨海默型病理的趋势。高可能性病例和中等可能性病例分别平均表现出3个临床核心特征中的0.44个和0.94个。另一方面,低可能性病例和LB阴性病例分别仅显示0.19和0.18。总之,它是适当的,包括高可能性和中间的情况下诊断DLB。少
英文摘要
The Hisayama study is a prospective population-based clinicopathological cohort in a Japanese subrural community, Hisayama Town. Most deceased subjects have been examined by autopsy to confirm causes of death and to examine brain pathology. These features have allowed a reliable estimation of the frequency of neurodegenerative diseases relating dementia in a general population and for a detailed analysis of the difference between dementia and non-dementia. In this study we obtained following findings.(1)We have estimated the frequency of senile dementia of the neurofibrillary tangle type (SD-NFT), which was fourth frequent type of dementia (3.9%). We found that the number of NFTs in the hippocampus of SD-NFT cases did not necessarily exceed the degree of those in Alzheimer's disease and that total brain weights were significantly reduced to the same extent as Alzheimer's disease (AD), which suggest that not only the limbic NFT pathology but also some whole brain dysfunctions might caus … More e the mental deterioration.(2)To explore cyclooxygenase(COX)-2 expression in the hippocampus, we analyzed 45 consecutive autopsy subjects without dementia and 25 AD patients. The neuronal expression of COX-2 in the CA3 subdivision of the hippocampus, subiculum, entorhinal cortex and transentorhinal cortex were consistently observed in both non-demented and AD brains and COX-2 immunoreactivity correlated with age in non-demented brains. In AD patients, neurons of CA1 exhibited increased COX-2 immunoreactivity which correlated with the severity of AD pathology, this correlation was not apparent in non-demented subjects. The results suggest that COX-2 expression may be differentially regulated among subdivisions of the hippocampus and that elevated COX-2 expression in the CA1 of AD brains may be associated with AD pathology and thus cognitive dysfunction.(3)Dementia with Lewy bodies (DLB) ranks the third major dementia. To verify the validity of the revised criteria in 2005, we have analyzed 205 consecutive demented autopsy cases. LB pathology was present in 59 cases (28.8%). Female cases with DLB have a tendency for more severe LB pathology and Alzheimer-type pathology as well. The high likelihood cases and intermediate cases exhibited 0.44 and 0.94 of 3 clinical core features each on average, respectively. On the other hand, the low likelihood cases and the LB-negative cases showed only 0.19 and 0.18 each. In conclusion, it is appropriate to include both the high likelihood and intermediate cases for diagnosis of DLB. Less
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/path.2009
发表时间: 2006-08-01
期刊: JOURNAL OF PATHOLOGY
影响因子: 7.3
作者: [Sasaki, K., Doh-ura, K., Iwaki, T.]
通讯作者: Iwaki, T.
DOI: 10.1111/j.1440-1789.2006.00722.x
发表时间: 2006-12
期刊: Neuropathology
影响因子: 2.3
作者: [K. Noda;K. Sasaki;Kohei Fujimi;Y. Wakisaka;Yumihiro Tanizaki;Y. Wakugawa;Y. Kiyohara;M. Iida;H. Aizawa;T. Iwaki]
通讯作者: K. Noda;K. Sasaki;Kohei Fujimi;Y. Wakisaka;Yumihiro Tanizaki;Y. Wakugawa;Y. Kiyohara;M. Iida;H. Aizawa;T. Iwaki
Aluminum chloride does not facilitate deposition of human synthetic amyloid beta 1-42 peptide in the rat ventricular system of a short-term infusion model.
氯化铝不会促进人合成淀粉样β1-42肽在短期输注模型的大鼠心室系统中的沉积。
DOI: --
发表时间: 2005
期刊: Neuropathology 25
影响因子: --
作者: [Saito, H., Somogyi J, Nakagawa Y]
通讯作者: Nakagawa Y
Styrylbenzoazole derivatives for imaging of prion plaques and treatment of transmissible spongiform encephalopatheis.
苯乙烯基苯并唑衍生物,用于朊病毒斑成像和传染性海绵状脑病的治疗。
DOI: --
发表时间: 2006
期刊: J. Neurochem. 99
影响因子: --
作者: [Toyoshima Y, Onodera O, Yamada M, Tsuji S, Kozak JA, Kozak JA, Matsushita M, Michiue H, Matsushita M, Wu HY, Michiue H, Matsushita M, Wu HY, Michiue H, Noguchi H, Wu HY, Matsushita M, Arataki S, Michiue H, Fujimi K, Fujimi K, Fujimi K, Sasaki K, Noda K, Ishikawa K]
通讯作者: Ishikawa K
共 7 条
    Molecular analysis of prion protein oligomers by single molecule fluorescence imaging
    • 批准号:
      24650186
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      IWAKI Toru
    • 依托单位:
    Association of life-style related risk factors with the pathology of dementia
    • 批准号:
      22300116
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.15万
    • 财政年份:
      2010
    • 负责人:
      IWAKI Toru
    • 依托单位:
    Clinicopathological study of risk factors for degenerative dementia : the Hisayama Study
    • 批准号:
      19300125
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.65万
    • 财政年份:
      2007
    • 负责人:
      IWAKI Toru
    • 依托单位:
    Molecular changes at the posterior horn of spinal cord resulting from spinal root avulsion
    • 批准号:
      12680733
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      2000
    • 负责人:
      IWAKI Toru
    • 依托单位:
    国内基金
    海外基金
    新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
    • 批准号:
      81000622
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2010
    • 负责人:
      梁胜
    • 依托单位:
    阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
    • 批准号:
      31060293
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      26.0万元
    • 批准年份:
      2010
    • 负责人:
      郭亚芬
    • 依托单位:
    跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究